Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 1:38 pm Unchanged |
2024-12-31 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
14,666,600 17.470% |
0 (Unchanged) |
Filing History |
| 2024-11-14 6:51 pm Sale |
2024-09-30 | 13G | aTyr Pharma, Inc. ATYR |
Logos Global Management LP | 1,750,000 2.100% |
-4,050,000 (-69.83%) |
Filing History |
| 2024-10-15 5:01 pm Purchase |
2024-10-14 | 13G | aTyr Pharma, Inc. ATYR |
Point72 Asset Management, L.P. | 5,039,846 6.200% |
5,039,846 (New Position) |
Filing History |
| 2024-10-07 1:36 pm Purchase |
2024-09-30 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
14,666,600 19.350% |
4,497,000 (+44.22%) |
Filing History |
| 2024-02-14 1:43 pm Sale |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
LYTTON LAURENCE W | 585,013 1.000% |
-3,855,175 (-86.82%) |
Filing History |
| 2024-02-13 4:30 pm Sale |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Stonepine Capital Management, LLC | 482,258 0.800% |
-4,087,175 (-89.45%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 8,784,009 14.999% |
4,432,602 (+101.87%) |
Filing History |
| 2024-01-18 10:17 am Purchase |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
10,169,600 17.370% |
4,938,000 (+94.39%) |
Filing History |
| 2024-01-02 12:21 pm Purchase |
2023-12-19 | 13G | aTyr Pharma, Inc. ATYR |
Logos Global Management LP | 5,800,000 9.900% |
5,800,000 (New Position) |
Filing History |
| 2023-02-22 1:40 pm Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
LYTTON LAURENCE W | 4,440,188 8.700% |
4,440,188 (New Position) |
Filing History |
| 2023-02-17 5:04 pm Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
Stonepine Capital Management, LLC | 4,569,433 8.900% |
4,569,433 (New Position) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,171,436 4.000% |
-393,564 (-25.15%) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 4,351,407 14.999% |
182,806 (+4.39%) |
Filing History |
| 2023-02-01 10:29 am Purchase |
2022-12-31 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
5,231,600 18.030% |
5,231,600 (New Position) |
Filing History |
| 2022-02-14 4:41 pm Sale |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Ikarian Capital LLC | 35,048 0.100% |
-853,532 (-96.06%) |
Filing History |
| 2022-02-14 4:17 pm Sale |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,565,000 5.600% |
-250,000 (-13.77%) |
Filing History |
| 2022-02-14 4:00 pm Purchase |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
TANG CAPITAL PARTNERS LP | 1,113,453 4.000% |
50,000 (+4.70%) |
Filing History |
| 2022-02-14 3:22 pm Sale |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Alyeska Investment Group, L.P. | 0 0.000% |
-842,554 (Position Closed) |
Filing History |
| 2022-02-14 1:26 pm Unchanged |
2021-12-31 | 13G | aTyr Pharma, Inc. LIFE |
FEDERATED HERMES INC. FHI |
5,222,250 18.790% |
0 (Unchanged) |
Filing History |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 4,168,601 14.999% |
2,492,721 (+148.74%) |
Filing History |